Thrombopoietin acts synergistically with LIF to maintain an undifferentiated state of embryonic stem cells homozygous for a Shp-2 deletion mutation  by Xie, Xiaodong et al.
Thrombopoietin acts synergistically with LIF to maintain
an undi¡erentiated state of embryonic stem cells homozygous
for a Shp-2 deletion mutation
Xiaodong Xie1, Rebecca J. Chan1, Mervin C. Yoder
Herman B Wells Center for Pediatric Research, Departments of Pediatrics and of Biochemistry and Molecular Biology,
Indiana University School of Medicine, 1044 W. Walnut Street, Indianapolis, IN 46202, USA
Received 20 June 2002; revised 26 August 2002; accepted 2 September 2002
First published online 19 September 2002
Edited by Ned Mantei
Abstract Thrombopoietin (Tpo) and its receptor, c-mpl, are
expressed in murine embryonic stem (ES) cells. ES cells are
maintained in a pluripotent state by leukemia inhibitory factor
(LIF) via activation of the Janus kinase (Jak)^STAT3 signaling
pathway. Tpo, like LIF, activates STAT3. We report that Tpo
increases the number of undi¡erentiated colonies derived from
wild type or Shp-2 mutant (Shp-2v46110) ES cells. Tpo plus LIF
acted synergistically on the Shp-2v46110 ES cells to maintain
undi¡erentiated colonies but no evidence of synergism via Jak^
STAT3 activation was detected. Collectively, these data suggest
that Tpo can play a role in preventing ES cell di¡erentiation via
Jak^STAT3 activation and perhaps via novel pathways that are
enhanced in the absence of functional Shp-2.
/ 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Thrombopoietin (Tpo) and its receptor (c-mpl) were iden-
ti¢ed as critical for normal megakaryocyte and platelet growth
[1^3]. However, Tpo has also been shown to be important for
the maintenance and growth of hematopoietic stem cells
(HSCs) [4,5]. The ¢rst clue regarding Tpo’s involvement in
HSC homeostasis was the observation that a truncated, con-
stitutively active form of the Tpo receptor encoded by v-mpl,
induced a myeloproliferative disorder in mice infected with
this oncogene [6]. HSCs from mice in which either the Tpo
or c-mpl locus is genetically disrupted do not undergo normal
self-renewal and di¡erentiation [4,5]. Additionally, Tpo has
been shown to mediate expansion of HSC ex vivo [7]. Given
the expanded function of Tpo from megakaryopoiesis to HSC
homeostasis, we were interested in examining its role in the
early murine embryo.
Embryonic stem (ES) cells are derived from the inner cell
mass of the developing blastocyst and are able to di¡erentiate
into multiple tissues in vitro [8]. Originally, ES cells were
cultured in the presence of mitotically inactivated murine ¢-
broblasts that produced ‘di¡erentiation inhibitory activity’
(DIA) which allowed for propagation with the maintenance
of ES cell pluripotency in culture. Subsequently, DIA was
found to be substitutable by leukemia inhibitory factor
(LIF) [9,10]. However, there is evidence that cytokines in ad-
dition to LIF have the capacity to maintain ES cells in an
undi¡erentiated state [11].
Shp-2 is a cytoplasmic tyrosine phosphatase with two SH2
domains at the N-terminus. ES cells homozygous for an exon
3 deletion from the Shp-2 locus causing an in-frame deletion
of amino acids 46^110 (Shp-2v46110), were found to be hyper-
sensitive to the di¡erentiation-inhibitory e¡ect of LIF [12] and
to have increased LIF-stimulated phospho-STAT3 (P-STAT3)
levels compared to wild type (WT) ES cells (Chan et al.,
manuscript in preparation). Several studies have demonstrated
that both Shp-2 and STAT3 are recruited and activated, re-
spectively, upon c-mpl stimulation [13^15]. Therefore, we have
examined the e¡ect of Tpo and the combination of Tpo plus
LIF on maintaining an undi¡erentiated state of WT and Shp-
2v46110 ES cells as well as on P-STAT3 levels in Shp-2v46110
ES cells.
Collectively, these studies show that Tpo-stimulated path-
ways are able to contribute to maintaining ES cells in an
undi¡erentiated state, although the e¡ect is more pronounced
in the Shp-2v46110 ES cells. Additionally, Tpo plus low con-
centrations of LIF act synergistically to maintain Shp-2v46110
in an undi¡erentiated state; however, the Tpo plus LIF-in-
duced P-STAT3 level in Shp-2v46110 ES cells was not in-
creased synergistically, suggesting that pathways in addition
to LIF- and Tpo-stimulated P-STAT3 are necessary to main-
tain ES cells in an undi¡erentiated state.
2. Materials and methods
2.1. ES cell culture and cell lines
ES cells were maintained on gelatinized plates in Dulbecco’s modi-
¢ed Eagle’s medium with 15% ES cell-quali¢ed fetal calf serum (Hy-
clone, Logan, UT, USA), 55 WM L-mercaptoethanol, and 1000 U/ml
LIF (ESGRO, Gibco BRL). The Shp-2v46110 ES cell line, IC3, has
been described previously [12,18].
2.2. Reverse-transcribed polymerase chain reaction (RT-PCR)
Total cellular RNA was prepared using TRIzol Reagent (Gibco
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BRL) according to the manufacturer’s instructions. First strand syn-
thesis of cDNA was performed using poly-dT primer and reverse
transcriptase (SuperScript1, Invitrogen, Carlsbad, CA, USA). Specif-
ic primers were used in nested PCR to amplify cDNA. Fragments
were subcloned into a TA Cloning Vector (Invitrogen) and sequenced
to verify fragment identity.
2.3. Colony di¡erentiation assay
WT and Shp-2v46110 ES cells were cultured at a colony dilution on
gelatinized plates for 5^7 days in ES cell LIF-containing media. The
resulting colonies were cultured for 96 h in media containing various
concentrations of LIF, recombinant human Tpo (rhTpo), and in some
assays, various concentrations of anti-rhTpo neutralizing antibody
(RpD, Minneapolis, MN, USA). The colonies were stained with
Giemsa and scored as di¡erentiated when surrounded by £attened,
¢broblast-like outgrowths. Additionally, colonies were stained with
alkaline phosphatase diagnostic kit R-86 (Sigma, St. Louis, MO,
USA). Colonies were scored as undi¡erentiated when the entire col-
ony was stained red and were scored as di¡erentiated when sur-
rounded by £attened, alkaline phosphatase-negative cells.
2.4. Immunoblot analysis and antibodies
Control and LIF-stimulated cell lysates were prepared as previously
described [19]. ES cells were cultured in serum-free, LIF-free main-
tenance media containing 0.5% bovine serum albumin (Sigma) for 6 h,
followed by stimulation for various times with LIF, Tpo or the com-
bination. Total cell lysates were electrophoresed on a 10% polyacryl-
amide gel followed by transfer to a nitrocellulose membrane. Anti-P-
STAT3 and anti-STAT3 were from New England Biolabs (Beverly,
MA, USA). Signals were detected by enhanced chemiluminescence.
2.5. Statistical analysis
Groups were compared using non-paired, two-sided, Student’s
t-test.
3. Results
3.1. Tpo and c-mpl are expressed in WT and Shp-2v 46110 ES
cells
Previous studies have indicated the presence of Tpo and
c-mpl messages in the murine embryo as early as 6.5 days
post coitum (Xie et al., manuscript submitted). Using RT-
PCR, we found both the Tpo and c-mpl messages expressed
in the murine blastocyst, WT ES cells, and Shp-2v46110 ES
cells (Fig. 1). We have sequenced the corresponding bands,
and found the expected sequences of Tpo and c-mpl (data not
shown). Negative controls utilizing water in lieu of template
yielded no Tpo or c-mpl bands (data not shown).
3.2. Tpo mediates an undi¡erentiated phenotype of WT and
Shp-2v 46110 ES cells
The presence of Tpo and c-mpl in ES cells prompted us to
examine their roles in ES cell function. WT and Shp-2v46110
ES cell colonies were cultured without LIF but in the presence
of 10 ng/ml Tpo or vehicle (phosphate-bu¡ered saline, PBS).
Nearly all of the WT colonies became di¡erentiated in the
presence of PBS (2% undi¡erentiated colonies, Fig. 2).
Upon the addition of Tpo, however, the number of undi¡er-
entiated colonies increased to 8%. The Shp-2v46110 cells had
more undi¡erentiated colonies compared to the WT cells
when cultured in the presence of PBS (2% vs. 5%, Fig. 2),
as described previously [12]. The addition of Tpo, however,
increased the number of undi¡erentiated colonies from 5% to
15% (Fig. 2). These data demonstrate that Tpo has the ca-
pacity to maintain ES cells in an undi¡erentiated state and
that the e¡ect appears to be stronger in the absence of normal
Shp-2 function.
3.3. Tpo acts synergistically with LIF to maintain an
undi¡erentiated phenotype of Shp-2v 46110 ES cells
Previous work demonstrated that the Shp-2v46110 cells are
hypersensitive to LIF signaling [12] ; therefore, we examined
the e¡ect of LIF and of Tpo plus LIF on maintaining an
undi¡erentiated ES cell phenotype. WT and Shp-2v46110 ES
cell colonies were cultured with vehicle (PBS), 10 ng/ml Tpo,
10 U/ml LIF, 10 ng/ml Tpo plus 10 U/ml LIF, 100 U/ml LIF,
or 1000 U/ml LIF. LIF at 100 or 1000 U/ml resulted in an
increased number of undi¡erentiated colonies for Shp-2v46110
compared to WT ES cells, consistent with previous studies
(Fig. 3A). The addition of Tpo to low concentrations of
LIF (10 U/ml) had no e¡ect on maintaining WT ES cells in
an undi¡erentiated state compared to 10 U/ml LIF alone (Fig.
3A). However, the combination of Tpo and LIF (10 U/ml)
caused a dramatic increase in the amount of undi¡erentiated
Shp-2v46110 colonies (Fig. 3A). The observation that this syn-
ergistic e¡ect is limited to the Shp-2v46110 cells implies that
Fig. 1. RT-PCR products of Tpo and c-mpl from WT blastocysts,
WT ES cells, and Shp-2v46110 ES cells.
Fig. 2. A: Percentage of undi¡erentiated ES cell colonies following
culture +/3 10 ng/ml Tpo. *P=0.07 comparing WT ES cells treated
with PBS vs. Tpo; **P=0.03 comparing WT to Shp-2v46110 ES
cells, both treated with PBS; ***P6 0.0001 comparing Shp-2v46110
ES cells treated with PBS vs. Tpo. B: Representative di¡erentiated
colony surrounded by £attened, ¢broblast-like cells. C: Representa-
tive undi¡erentiated, well-circumscribed colony.
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Shp-2 functions to down-regulate Tpo-stimulated signaling
pathways, similar to LIF-stimulated pathways (Chan et al.,
manuscript in preparation).
To determine speci¢cally the contribution of Tpo signaling
to this synergistic e¡ect, we examined the consequences of
adding Tpo-neutralizing antibody to these cultures. The
Tpo-neutralizing antibody blocks binding of Tpo to its recep-
tor, c-mpl. Addition of the Tpo-neutralizing antibody (either
at 10 or 100 ng/ml) decreased the undi¡erentiated colony
number (Fig. 3B), in contrast to what is observed when con-
trol antibody was added. These data demonstrate that Tpo
signaling via c-mpl strongly contributes to the undi¡erentiated
Shp-2v46110 ES cell phenotype induced by the Tpo plus LIF
combination, and that this synergistic e¡ect is not due solely
to hypersensitivity of the Shp-2v46110 ES cells to LIF.
To examine further the e¡ect of Tpo and LIF on maintain-
ing an undi¡erentiated state of Shp-2v46110 cells, colonies
were also subjected to alkaline phosphatase activity examina-
tion, as alkaline phosphatase levels are known to decrease
upon ES cell di¡erentiation [20]. As observed in the morphol-
ogy assay, the addition of 10 ng/ml Tpo alone resulted in an
increased number of undi¡erentiated Shp-2v46110 colonies
compared to PBS (Fig. 4A). Additionally, the combination
of 10 U/ml LIF plus 10 ng/ml Tpo caused a synergistic in-
crease in the number of undi¡erentiated Shp-2v46110 colonies.
3.4. Tpo induces activation of STAT3 in ES cells, but does not
act synergistically with LIF to activate STAT3
P-STAT3 has been shown to be crucial for the maintenance
of ES cells in an undi¡erentiated state [16,17] and for self-
renewal of ES cells [21,22]. We sought to determine if Tpo
induced activation of STAT3 in Shp-2v46110 ES cells. We
found that Tpo stimulation causes activation of STAT3 in
a dose-dependent manner (Fig. 5A). We next examined the
e¡ect of 10 ng/ml Tpo plus 10 U/ml LIF stimulation on
P-STAT3 levels, as these doses produced the synergistic in-
crease in the number of undi¡erentiated colonies. However,
the level of P-STAT3 was not increased upon treatment with
10 ng/ml Tpo plus 10 u/ml LIF compared to treatment with
10 u/ml LIF alone (Fig. 5B). We did, however, observe an
increase in P-STAT3 upon treatment with 100 or 1000 U/ml
LIF, correlating well with LIF doses at which the Shp-2v46110
Fig. 3. A: Percentage of undi¡erentiated colonies after culture with
PBS, 10 ng/ml Tpo, 10 U/ml LIF, 10 U/ml LIF plus 10 ng/ml Tpo,
100 U/ml LIF, or 1000 U/ml LIF. *P6 0.0001 comparing Shp-
2v46110 ES cells treated with 10 U/ml LIF vs. 10 U/ml LIF plus 10
ng/ml Tpo; ** and ***P6 0.0001 comparing WT to Shp-2v46110
ES cells treated with 100 U/ml or 1000 U/ml LIF, respectively.
B: Percentage of undi¡erentiated Shp-2v46110 ES cell colonies after
culture with 10 U/ml LIF plus 10 ng/ml Tpo +/3 varying concen-
trations of anti-Tpo neutralizing antibody or control antibody.
*P=0.0016 and **P6 0.0001 comparing addition of anti-Tpo at
10 ng/ml and 100 ng/ml, respectively, to 10 U/ml LIF plus 10 ng/ml
Tpo alone.
Fig. 4. A: Alkaline phosphatase staining of Shp-2v46110 ES cell col-
onies after culture in the presence of PBS, 10 ng/ml Tpo, 10 U/ml
LIF, 10 U/ml LIF plus 10 ng/ml Tpo, 100 U/ml LIF, or 1000 U/ml
LIF. *P=0.02 comparing treatment with 10 ng/ml Tpo vs. PBS;
**P6 0.0001 comparing treatment with 10 U/ml LIF plus 10 ng/ml
Tpo vs. 10 ng/ml Tpo. B: Representative undi¡erentiated colony
strongly stained for alkaline phosphatase. C: Representative di¡er-
entiated colony surrounded by alkaline phosphatase-negative cells.
Fig. 5. A: Shp-2v46110 ES cells were unstimulated (dashed line) or
stimulated with 10 ng/ml, 50 ng/ml, or 100 ng/ml Tpo, for 10, 30,
or 90 min followed by immunoblot analysis for P-STAT3 and
STAT3. B: Shp-2v46110 ES cells were unstimulated (dashed line) or
stimulated with 10 ng/ml Tpo plus 10 U/ml LIF, 10 U/ml LIF,
100 U/ml LIF, or 1000 U/ml LIF for 10 and 30 min followed by
immunoblot analysis for P-STAT3 and STAT3.
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cells demonstrated LIF hypersensitivity in the colony studies
above, suggesting that a synergistic e¡ect of 10 ng/ml Tpo
plus 10 U/ml LIF on P-STAT3 levels could be detected if
present.
4. Discussion
Tpo was originally found to be a megakaryocytic growth
factor [1^3] and subsequently was found to be important for
HSC homeostasis [4,5]. We have demonstrated that Tpo can
mediate ES cell function as well, namely, by inhibiting ES cell
di¡erentiation in vitro. Previously, Filippi et al. reported Tpo-
induced e¡ects on ES cell-derived hematopoiesis [23]. In this
study, we have demonstrated Tpo-mediated functional e¡ects
on ES cells rather that ES cell-derived hematopoietic cells.
The presence of Tpo and c-mpl in the early murine embryo
and blastocyst suggested a potential role in ES cell function.
We examined the e¡ect of Tpo on WT and Shp-2v46110 ES
cells, as Shp-2 has been shown to be critical in mediating
normal LIF-regulated ES cell function [12]. We found that
both Tpo and c-mpl are expressed in WT and Shp-2v46110
ES cells. Although we evaluated RNA levels rather than pro-
tein levels, we believe the response of ES cells to Tpo stimu-
lation in the form of P-STAT3 is strong evidence that c-mpl
protein is expressed and is functional on ES cells.
As Tpo sustains HSC in an undi¡erentiated and self-renew-
ing state in vitro [7], we sought to determine the capacity of
Tpo to maintain ES cells in an undi¡erentiated state com-
pared to LIF, the cytokine used routinely to maintain ES
cell pluripotency in vitro. Compared to PBS only (vehicle),
Tpo increased the number of ES cell colonies that remained
undi¡erentiated. This e¡ect was more pronounced in the Shp-
2v46110 ES cells compared to the WT cells, and the e¡ect was
not nearly as great as the e¡ect of LIF (1000 U/ml) for either
cell line. These data demonstrate that Tpo is able to partic-
ipate in maintaining an undi¡erentiated state of ES cells, but
is not su⁄cient to do so.
We next examined the combination of Tpo plus LIF on ES
cell function and found that Tpo worked synergistically with
LIF to maintain Shp-2v46110 ES cell colonies in an undi¡er-
entiated state as determined both morphologically and by
alkaline phosphatase staining. The synergistic e¡ect of Tpo
was blocked by neutralizing antibody, indicating that Tpo
stimulation contributes signi¢cantly to this synergism. That
the dose-dependent e¡ect of the neutralizing antibody was
not stronger is likely because 10 ng/ml antibody is adequate
to block the low concentration (10 ng/ml) of added Tpo. The
fact that we observed a more pronounced e¡ect of Tpo and
the Tpo plus LIF combination on the Shp-2v46110 ES cells
implies that the absence of normal Shp-2 function confers
increased sensitivity of the Shp-2v46110 ES cells to Tpo signal-
ing and suggests that Shp-2 acts to down-regulate Tpo signal-
ing in WT ES cells.
As LIF-stimulated P-STAT3 is necessary to maintain ES
cells in an undi¡erentiated state [16] and promotes ES cell
self-renewal [21,22], and as Tpo is known to signal to
STAT3, we investigated STAT3 as a potential molecule down-
stream of Tpo and LIF that may mediate the synergistic e¡ect
observed in the Shp-2v46110 ES cells. Consistent with Tpo
activation of STAT3 as reported [13,14], phosphorylation of
STAT3 was observed in a dose-dependent manner upon stim-
ulation of the Shp-2v46110 cells. However, surprisingly, we did
not observe a synergistic increase in the level of P-STAT3
upon stimulation with LIF plus Tpo, in contrast to the dra-
matic functional changes observed upon treatment of the Shp-
2v46110 ES cell colonies. These data indicate that signaling
molecules downstream of LIF and Tpo in addition to
STAT3 are necessary for maintenance of ES cells in an un-
di¡erentiated state and suggest that ES cell pluripotency is
maintained through the e¡ect of multiple cytokines, working
through parallel and potentially overlapping pathways.
The in vitro data presented above demonstrate that exoge-
nously added Tpo can contribute to the maintenance of ES
cells in an undi¡erentiated state. However, the relevance of
the observed Tpo e¡ect in vivo on the early murine embryo
remains to be examined. The Tpo3/3 and c-mpl3/3 mice
provide excellent models to study these novel roles of Tpo
and c-mpl function in early embryogenesis.
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